Updated COVID-19 Vaccines Benefit Autoimmune Rheumatic Patients

An analysis of U.S. adult data indicates that individuals with autoimmune rheumatic conditions who received updated (2023-2024) or booster COVID-19 vaccines were less likely to be hospitalized compared to those with only initial doses or who were unvaccinated. This finding reinforces the importance of current vaccination recommendations for vulnerable populations, highlighting continued protection against severe COVID-19 outcomes.